DUSA Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

WILMINGTON, Mass., May 31, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Jefferies 2012 Global Healthcare Conference in New York City. The conference is being held at the Grand Hyatt Hotel, June 4-7, 2012. Mr. Doman is scheduled to present at 2:30 p.m. EDT on June 7, 2012To access the live webcast of the presentation, interested parties can click here or visit our website at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website shortly following the presentation.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform. Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% plus blue light illumination using DUSA's BLU-U® Blue Light Photodynamic Therapy Illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. 

CONTACT: Chad Rubin
         The Trout Group LLC
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here